Age
Item
over or equal to 18 years of age.
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status less than or equal to 1
boolean
C1520224 (UMLS CUI [1])
Organ function
Item
adequate organ function.
boolean
C0678852 (UMLS CUI [1])
Radical prostatectomy | Adenocarcinoma of prostate
Item
history of radical prostatectomy with histopathologic documentation of adenocarcinoma of the prostate.
boolean
C0194810 (UMLS CUI [1])
C0007112 (UMLS CUI [2])
PSA measurement | PSA Undetectable | PSA Progression Sample Consecutive Quantity
Item
psa over or equal to 0.2 ng/ml or less than or equal to 0.4 ng/ml. this includes patients whose psa never becomes detectable. psa progression must be measured by two consecutive samples, each separated by over or equal to 7 days. the psa values of the two consecutive sample values must be greater than the previous (baseline) value, not greater than each other.
boolean
C0201544 (UMLS CUI [1])
C0138741 (UMLS CUI [2,1])
C3827727 (UMLS CUI [2,2])
C4054264 (UMLS CUI [3,1])
C0370003 (UMLS CUI [3,2])
C1707491 (UMLS CUI [3,3])
C1265611 (UMLS CUI [3,4])
Site Known Prostate carcinoma Measurable | Secondary malignant neoplasm of prostate Bone scan Positive | ProstaScint Scan Positive allowed
Item
known sites of measurable prostate cancer or bone scan positive for metastatic prostate cancer. (patients with a positive prostascint scan will not be excluded)
boolean
C1515974 (UMLS CUI [1,1])
C0205309 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
C1513040 (UMLS CUI [1,4])
C0347001 (UMLS CUI [2,1])
C0203668 (UMLS CUI [2,2])
C1514241 (UMLS CUI [2,3])
C2985362 (UMLS CUI [3,1])
C1514241 (UMLS CUI [3,2])
C0683607 (UMLS CUI [3,3])
Therapeutic procedure Prostate carcinoma | Exception Radical prostatectomy | Exception Hormone Therapy Neoadjuvant | Chemotherapy | Hormone Therapy | Therapeutic radiology procedure | Biological treatment
Item
prior therapy for prostate cancer except rp and neoadjuvant hormonal therapy. this includes chemo, hormonal (except neoadjuvant), rt, and biologic therapy.
boolean
C0087111 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0194810 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0279025 (UMLS CUI [3,2])
C0600558 (UMLS CUI [3,3])
C0392920 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
C1522449 (UMLS CUI [6])
C1531518 (UMLS CUI [7])
Upper gastrointestinal tract Integrity Lacking | Malabsorption Syndrome | Intolerance to oral medication | Oral medication Intake Unable | Crohn Disease | Ulcerative Colitis
Item
lack of physical integrity of the upper gi tract, malabsorption syndromes, or inability to tolerate or absorb oral medications, including crohn's disease and ulcerative colitis.
boolean
C1268997 (UMLS CUI [1,1])
C1947912 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
C0024523 (UMLS CUI [2])
C1744706 (UMLS CUI [3,1])
C0175795 (UMLS CUI [3,2])
C0175795 (UMLS CUI [4,1])
C1512806 (UMLS CUI [4,2])
C1299582 (UMLS CUI [4,3])
C0010346 (UMLS CUI [5])
C0009324 (UMLS CUI [6])
Immunotherapy Investigational | Therapeutic radiology procedure Investigational | Chemotherapy Investigational | Therapeutic procedure Ancillary Investigational
Item
other concurrent immunotherapy, rt, chemotherapy,or ancillary therapy considered investigational (utilized for non-fda approved indications and the context of a research investigation)and any chemotherapy not included in the study protocol.
boolean
C0021083 (UMLS CUI [1,1])
C1517586 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C1517586 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3,1])
C1517586 (UMLS CUI [3,2])
C0087111 (UMLS CUI [4,1])
C1549485 (UMLS CUI [4,2])
C1517586 (UMLS CUI [4,3])